All adults who achieve full or partial remission and have 1 or more risk factor for relapse should discuss with their healthcare professional whether they need to continue treatment. They should, ...
Extended-release naltrexone, a sustained-release monthly injectable formulation of the full mu-opioid receptor antagonist, is effective for the prevention of relapse to opioid dependence. Data ...
Prevention of relapse is a major goal of maintenance treatment in patients with psychotic disorders. We performed a long-term comparison of a newer, atypical antipsychotic drug, risperidone, and an ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results